The European Union and the International AIDS Vaccine Initiative havestrengthened their joint efforts to promote the accelerated development of preventive AIDS vaccines and speed their availability in developing countries. Vaccines provide the best hope of ending the AIDS pandemic in the long term, the EU/AIVI told the African HIV/AIDS Summit, and they will work to accelerate R&D programs and organize effective public/private support to clinical trial platforms.
The partners say they will also work with developing countries to build capacity and ensure adequate vaccine preparedness in advance of large-scale clinical trials.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze